Monitoring of renal, hepatic and hematopoietic function should be performed at regular intervals during long-term treatment with bisoprolol hemifumarate.
Use in pregnancy: The safety of bisoprolol hemifumarate during pregnancy has not been established.
Use in lactation: No data is available for lactation.
Use in children: Safety and effectiveness in children have not been established.